SAN DIEGO--(BUSINESS WIRE)--BioMed Realty (“BioMed” or the “Company”), a leading owner and operator of life science real estate, announced today the promotions and expanded portfolio responsibilities of Jon Bergschneider to President – West Coast Markets and Bill Kane to President – East Coast & UK Markets. In addition, Tracy Perrelle was promoted to Senior Vice President, Property Management in charge of West Coast operations. These three executives, who have a combined total of more than five decades of experience in life science real estate and 24 years of total experience at BioMed, will help lead and continue to grow the Company’s fully integrated life science real estate platform.
Mr. Bergschneider is currently serving as BioMed’s EVP and Chief Development Officer, and Mr. Kane as BioMed’s EVP, East Coast & UK Markets. As President of their respective markets, Mr. Bergschneider and Mr. Kane will each have expanded leadership responsibilities including leasing, development and operations of their integrated teams, and will collaboratively grow and expand BioMed’s premier portfolio together. They will continue to report to Chief Executive Officer Tim Schoen and be supported by over 200 dedicated BioMed professionals globally.
In addition to the promotions from within BioMed’s experienced management team, the Company also appointed Ryan Anderson to the executive team as its new Chief Investment Officer starting February 2021 and reporting to the CEO. Mr. Anderson brings over a decade of institutional life science real estate acquisition experience gained by helping grow one of the largest national portfolios in the United States. He joins BioMed after most recently holding the position of Senior Vice President, Life Science Estates at Healthpeak Properties, Inc. (NYSE: PEAK) since 2019. Prior to that, Mr. Anderson served in various capacities across the Life Science and Transactions functions within Healthpeak since 2004.
“The promotions announced today are well-deserved, and a recognition of each executive’s substantial contribution to BioMed Realty. Bill, Jon and Tracy have decades of experience serving the unique needs of established and growing life science and technology communities, and have helped our clients advance their research and scientific objectives,” said Tim Schoen, CEO of BioMed Realty. “Bill and Jon have been an integral part of our success delivering exceptional portfolio performance. As our new Presidents, their leadership, deep relationships, operational experience and development expertise will help accelerate the Company’s growth strategy in the top innovation markets in the U.S. and the U.K. This new management structure is designed to further promote the team’s speed and cohesiveness when addressing our clients’ needs, which will serve us well as we begin our new chapter in Blackstone’s long-term, Core+ real estate ownership vehicle.”
Regarding the addition of Mr. Anderson as Chief Investment Officer, Mr. Schoen further stated that “The unique opportunity to add a proven veteran like Ryan, with 12 years of experience in the life science real estate industry, to our senior team further strengthens our foundation for future growth. We are very excited to welcome him to our team.”
About BioMed Realty
BioMed Realty, a Blackstone portfolio company, is a leading provider of real estate solutions to the life science and technology industries. As of December 31, 2020, BioMed owns and operates high quality life science real estate comprising 11.4 million square feet concentrated in leading innovation markets throughout the United States and United Kingdom, including Boston/Cambridge, San Francisco, San Diego, Seattle and Cambridge, U.K. In addition, BioMed maintains a premier development platform with 2.8 million square feet of Class A properties in active construction to meet the growing demand of the life science industry. To learn more about BioMed Realty, visit biomedrealty.com and follow the company on Twitter @biomedrealty.